Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05601440
Title Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Canadian Cancer Trials Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN

Facility Status City State Zip Country Details
Arthur J.E. Child Comprehensive Cancer Centre RECRUITING Calgary Alberta T2N 5G2 Canada Details
BCCA - Kelowna RECRUITING Kelowna British Columbia V1Y 5L3 Canada Details
BCCA - Vancouver RECRUITING Vancouver British Columbia V5Z 4E6 Canada Details
QEII Health Sciences Centre RECRUITING Halifax Nova Scotia B3H 1V7 Canada Details
Juravinski Cancer Centre at Hamilton Health Sciences RECRUITING Hamilton Ontario L8V 5C2 Canada Details
Kingston Health Sciences Centre RECRUITING Kingston Ontario K7L 2V7 Canada Details
Ottawa Hospital Research Institute RECRUITING Ottawa Ontario K1H 8L6 Canada Details
Odette Cancer Centre SUSPENDED Toronto Ontario M4N 3M5 Canada Details
University Health Network RECRUITING Toronto Ontario M5G 2M9 Canada Details
The Jewish General Hospital RECRUITING Montreal Quebec H3T 1E2 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field